Literature DB >> 21318566

MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study.

Andrew C Parrott1, Amy Gibbs, Andrew B Scholey, Rebecca King, Katherine Owens, Phil Swann, Ed Ogden, Con Stough.   

Abstract

RATIONALE: This study investigated the acute mood effects of oral MDMA, methamphetamine, and placebo in a double-blind laboratory study.
METHODS: Fifty-two healthy participants comprised abstinent recreational users of stimulant drugs, 27 female and 25 male, mean age 24.8 years. Three test sessions involved acute 100 mg oral 3.4-methylendioxymethamphetamine (MDMA), 0.42 mg/kg oral methamphetamine, and matching placebo. Drug administration was counterbalanced, testing was double-blind, and medical supervision was present throughout. Car-driving performance on a laboratory simulator was assessed after 3 and 24 h, with the findings being presented elsewhere. Positive and negative moods (PANAS self-ratings) were completed before drug administration, 3, 4.5, and 24 h later. Blood samples were taken to monitor drug plasma levels.
RESULTS: Following MDMA, there were no significant increases in positive moods, whereas negative moods were significantly higher than under placebo. Methamphetamine led to significant increases in both positive and negative moods. The MDMA findings contrast with the elated moods, typically noted by dance clubbers on Ecstasy. However, they are consistent with some previous laboratory findings, since a wide array of positive and negative mood changes have been demonstrated. One possible explanatory factor was the neutral environmental situation, particularly if a primary action of MDMA is to intensify ongoing psychological states. Other explanatory factors, such as dosage, gender, post-drug timing, neurohormonal aspects, and social factors, are also discussed.
CONCLUSIONS: In the laboratory, acute methamphetamine led to significantly higher positive moods. However, against expectations, MDMA did not generate a significant increase in positive moods.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21318566     DOI: 10.1007/s00213-011-2184-9

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  52 in total

Review 1.  A review of the clinical pharmacology of methamphetamine.

Authors:  Christopher C Cruickshank; Kyle R Dyer
Journal:  Addiction       Date:  2009-04-29       Impact factor: 6.526

2.  Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration.

Authors:  G J H Dumont; F C G J Sweep; R van der Steen; R Hermsen; A R T Donders; D J Touw; J M A van Gerven; J K Buitelaar; R J Verkes
Journal:  Soc Neurosci       Date:  2009       Impact factor: 2.083

3.  Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users.

Authors:  S J Peroutka; H Newman; H Harris
Journal:  Neuropsychopharmacology       Date:  1988-12       Impact factor: 7.853

4.  Methamphetamine self-administration by humans.

Authors:  C L Hart; A S Ward; M Haney; R W Foltin; M W Fischman
Journal:  Psychopharmacology (Berl)       Date:  2001-08       Impact factor: 4.530

5.  Is ecstasy an "empathogen"? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others.

Authors:  Gillinder Bedi; David Hyman; Harriet de Wit
Journal:  Biol Psychiatry       Date:  2010-10-14       Impact factor: 13.382

6.  Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics.

Authors:  M Farré; R de la Torre; B O Mathúna; P N Roset; A M Peiró; M Torrens; J Ortuño; M Pujadas; J Camí
Journal:  Psychopharmacology (Berl)       Date:  2004-04-08       Impact factor: 4.530

7.  Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP.

Authors:  Manuel Tancer; Chris-Ellyn Johanson
Journal:  Drug Alcohol Depend       Date:  2003-10-24       Impact factor: 4.492

8.  Physiological and subjective responses to controlled oral 3,4-methylenedioxymethamphetamine administration.

Authors:  Erin A Kolbrich; Robert S Goodwin; David A Gorelick; Robert J Hayes; Elliot A Stein; Marilyn A Huestis
Journal:  J Clin Psychopharmacol       Date:  2008-08       Impact factor: 3.153

9.  Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.

Authors:  A C Parrott; J Lasky
Journal:  Psychopharmacology (Berl)       Date:  1998-10       Impact factor: 4.530

Review 10.  A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers.

Authors:  G J H Dumont; R J Verkes
Journal:  J Psychopharmacol       Date:  2006-03       Impact factor: 4.153

View more
  17 in total

1.  Basal functioning of the hypothalamic-pituitary-adrenal (HPA) axis and psychological distress in recreational ecstasy polydrug users.

Authors:  Mark A Wetherell; Catharine Montgomery
Journal:  Psychopharmacology (Berl)       Date:  2013-11-05       Impact factor: 4.530

2.  An examination of sociodemographic correlates of ecstasy use among high school seniors in the United States.

Authors:  Joseph J Palamar; Dimitra Kamboukos
Journal:  Subst Use Misuse       Date:  2014-06-23       Impact factor: 2.164

3.  Methamphetamine affects cell proliferation in the medial prefrontal cortex: a new niche for toxicity.

Authors:  Airee Kim; Chitra D Mandyam
Journal:  Pharmacol Biochem Behav       Date:  2014-09-28       Impact factor: 3.533

4.  Mechanisms and environmental factors that underlying the intensification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced serotonin syndrome in rats.

Authors:  Rui Tao; Ibrahim M Shokry; John J Callanan; H Daniel Adams; Zhiyuan Ma
Journal:  Psychopharmacology (Berl)       Date:  2014-10-11       Impact factor: 4.530

5.  Acupuncture inhibition of methamphetamine-induced behaviors, dopamine release and hyperthermia in the nucleus accumbens: mediation of group II mGluR.

Authors:  Nam Jun Kim; Yeonhee Ryu; Bong Hyo Lee; Suchan Chang; Yu Fan; Young S Gwak; Chae Ha Yang; Kyle B Bills; Scott C Steffensen; Jin Suk Koo; Eun Young Jang; Hee Young Kim
Journal:  Addict Biol       Date:  2018-01-23       Impact factor: 4.280

6.  Levels of neural progenitors in the hippocampus predict memory impairment and relapse to drug seeking as a function of excessive methamphetamine self-administration.

Authors:  Patrick Recinto; Anjali Rose H Samant; Gustavo Chavez; Airee Kim; Clara J Yuan; Matthew Soleiman; Yanabel Grant; Scott Edwards; Sunmee Wee; George F Koob; Olivier George; Chitra D Mandyam
Journal:  Neuropsychopharmacology       Date:  2011-12-28       Impact factor: 7.853

7.  The acute effects of 3,4-methylenedioxymethamphetamine and d-methamphetamine on human cognitive functioning.

Authors:  Con Stough; Rebecca King; Katherine Papafotiou; Phillip Swann; Edward Ogden; Keith Wesnes; Luke A Downey
Journal:  Psychopharmacology (Berl)       Date:  2011-10-22       Impact factor: 4.530

8.  Psychiatric profiles of mothers who take Ecstasy/MDMA during pregnancy: reduced depression 1 year after giving birth and quitting Ecstasy.

Authors:  John J D Turner; Andrew C Parrott; Julia Goodwin; Derek G Moore; Sarah Fulton; Meeyoung O Min; Lynn T Singer
Journal:  J Psychopharmacol       Date:  2013-12-10       Impact factor: 4.153

9.  Influence of chronic caffeine on MDMA-induced behavioral and neuroinflammatory response in mice.

Authors:  Jessica Ruiz-Medina; Ana Pinto-Xavier; Marta Rodríguez-Arias; José Miñarro; Olga Valverde
Journal:  Psychopharmacology (Berl)       Date:  2012-11-29       Impact factor: 4.530

10.  Abuse potential of methylenedioxymethamphetamine (MDMA) and its derivatives in zebrafish: role of serotonin 5HT2-type receptors.

Authors:  Luisa Ponzoni; Daniela Braida; Mariaelvina Sala
Journal:  Psychopharmacology (Berl)       Date:  2016-06-18       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.